Merit Medical Systems Inc 2026年季度报告

☒QUARTERLY REPORT PURSUANT TO SECTION13 OR 15(d)OF THE SECURITIESEXCHANGE ACT OF 1934For the quarterly period ended March31,2026 OR ☐TRANSITION REPORT PURSUANT TO SECTION13 OR 15(d)OF THE SECURITIESEXCHANGE ACT OF 1934For the transition period fromto. Commission File Number0-18592 MERIT MEDICAL SYSTEMS,INC.(Exact name of registrant as specified in its charter) Utah87-0447695(State or other jurisdiction of incorporation or organization)(IRS Employer Identification No.) 1600 West Merit Parkway, South Jordan, Utah 84095(Address of principal executive offices, including zip code)Registrant’s telephone number, including area code:(801) 253-1600 Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d)of theSecurities Exchange Act of 1934 during the preceding 12months (or for such shorter period that the registrant wasrequired to file such reports) and (2)has been subject to filing requirements for the past 90days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to besubmitted pursuant to Rule405 of Regulation S-T during the preceding 12months (or for such shorter period that theregistrant was required to submit such files). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, asmaller reporting company or an emerging growth company.See the definitions of “large accelerated filer,”“accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule12b-2 of the Exchange Act. Large AcceleratedFiler☒AcceleratedFiler☐Non-Accelerated Filer☐SmallerReportingCompany☐EmergingGrowthCompany☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transitionperiod for complying with any new or revised financial accounting standards provided pursuant to Section13(a)of theExchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Exchange Act). Yes☐No☒ Indicate the number of shares outstanding of each of the Registrant’s classes of common stock, as of the latestpracticable date. 59,654,855Shares outstanding as of April 28, 2026 Title or class Common Stock, no par value TABLE OF CONTENTS PART I.FINANCIAL INFORMATION3Item 1.Financial Statements (Unaudited)3Consolidated Balance Sheets3Consolidated Statements of Income5Consolidated Statements of Comprehensive Income6Consolidated Statements of Stockholders’ Equity7Consolidated Statements of Cash Flows8Condensed Notes to Consolidated Financial Statements10Item 2.Management’s Discussion and Analysis of Financial Condition and Results ofOperations27Item 3.Quantitative and Qualitative Disclosures About Market Risk33Item 4.Controls and Procedures34PART II.OTHER INFORMATION35Item 1.Legal Proceedings35Item 1A.Risk Factors35Item5.Other information35Item 6.Exhibits37SIGNATURE39 PARTI- FINANCIAL INFORMATION MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS(In thousands) MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS(In thousands) March31,December31,LIABILITIES AND STOCKHOLDERS’ EQUITY20262025(unaudited)Current liabilities:Trade payables$67,853$60,551Accrued expenses122,515159,486Short-term operating lease liabilities11,22810,876Income taxes payable15,2788,851Total current liabilities216,874239,764Long-term debt735,160734,038Deferred income tax liabilities19,66419,665Liabilities related to unrecognized tax benefits2,2482,248Deferred compensation payable17,37317,542Deferred credits1,3731,398Long-term operating lease liabilities75,17576,658Other long-term obligations24,68910,306Total liabilities1,092,5561,101,619Commitments and contingenciesStockholders' equity:Preferred stock — 5,000 shares authorized; no shares issued as ofMarch31,2026 and December31,2025——Common stock, no par value — 100,000 shares authorized; issued andoutstanding as of March31,2026-59,655 and December31,2025-59,424769,271763,909Retained earnings865,025824,030Accumulated other comprehensive loss(7,568)(3,636)Total stockholders’ equity1,626,7281,584,303Total liabilities and stockholders’ equity$2,719,284$2,685,922See condensed notes to consolidated financial statements.(concluded) MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF INCOME(In thousands, except per share amounts- unaudited) MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME(In thousands- unaudited) MERIT MEDICAL SYSTEMS,INC.CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY(In thousands- unaudited) MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWS(In thousands- unaudited) MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWS(In thousands- unaudited) 20262025CASH FLOWS FROM FINANCING ACTIVITIES:P